Literature DB >> 24009645

TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Patricia M Pacheco1, Benjamin LE, David White, Todd Sulchek.   

Abstract

The complement system is an integral innate immune component that is made up of a cascade of enzymatic proteins that, once activated, results in lysis of invading pathogens, opsonization or recruitment of other innate and/or acquired immune responders, or some combination of the three. Due to the importance of the signal amplification and control points present in the cascade, complement is highly sensitive to subtle variations in initiation conditions, including nanoscale changes to molecular spacing. Using Fc-functionalized microparticles and nanoparticles, we find that activation requires a minimum threshold surface concentration of Fc of at least 20% surface coverage. This result indicates that a high surface density Fc is necessary for micro/nanoparticle complement activation through the classical pathway. In addition, the magnitude of the response was dependent on the size of the particle, with larger particles causing decreased activation. We hypothesize that a high density of Fc is needed to efficiently bind and closely appose molecular initiators of the complement cascade, from initiation to terminal complement complex formation. These fundamental studies of the interaction of microparticles and nanoparticles with the immune system suggest design rules for particle size and molecular density that impact immunostimulation through the complement system. Providing a therapeutic agent to modulate the complement response could aid a variety of treatment strategies. Engineered nanoparticles with controlled gaps between molecular activators could lead to new types of immunomodulatory agents.

Entities:  

Keywords:  Complement system; Fc; immunomodulation; microparticles and nanoparticles

Year:  2013        PMID: 24009645      PMCID: PMC3759286          DOI: 10.1142/S1793984413410018

Source DB:  PubMed          Journal:  Nano Life        ISSN: 1793-9844


  55 in total

Review 1.  The immune system. First of two parts.

Authors:  P J Delves; I M Roitt
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

Review 2.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

Authors:  Fakhrul Ahsan; Isabel P Rivas; Mansoor A Khan; Ana I Torres Suarez
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

Review 3.  Nano and microparticles as controlled drug delivery devices.

Authors:  M N Ravi Kumar
Journal:  J Pharm Pharm Sci       Date:  2000 May-Aug       Impact factor: 2.327

Review 4.  Parameters influencing the stealthiness of colloidal drug delivery systems.

Authors:  Arnaud Vonarbourg; Catherine Passirani; Patrick Saulnier; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2006-05-02       Impact factor: 12.479

5.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

6.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.

Authors:  Paul Gallo; Ricardo Gonçalves; David M Mosser
Journal:  Immunol Lett       Date:  2010-07-27       Impact factor: 3.685

Review 7.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 8.  Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

Authors:  Janos Szebeni; Franco Muggia; Alberto Gabizon; Yechezkel Barenholz
Journal:  Adv Drug Deliv Rev       Date:  2011-07-14       Impact factor: 15.470

9.  Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.

Authors:  S Moein Moghimi; A Christy Hunter; Christopher M Dadswell; Sandor Savay; Carl R Alving; Janos Szebeni
Journal:  Biochim Biophys Acta       Date:  2004-06-28

10.  Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?

Authors:  Michael A Flierl; Jennifer L Gaudiani; Allison L Sabel; Carlin S Long; Philip F Stahel; Philip S Mehler
Journal:  Ann Gen Psychiatry       Date:  2011-05-04       Impact factor: 3.455

View more
  7 in total

1.  A Liquid-Handling Robot for Automated Attachment of Biomolecules to Microbeads.

Authors:  Aaron Enten; Yujia Yang; Zihan Ye; Ryan Chu; Tam Van; Ben Rothschild; Francisco Gonzalez; Todd Sulchek
Journal:  J Lab Autom       Date:  2015-08-26

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

3.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

4.  Materials design at the interface of nanoparticles and innate immunity.

Authors:  Gregory Lee Szeto; Erin B Lavik
Journal:  J Mater Chem B       Date:  2016-01-29       Impact factor: 6.331

5.  Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells.

Authors:  Jiaying Liu; Randall Toy; Casey Vantucci; Pallab Pradhan; Zijian Zhang; Katie M Kuo; Kelsey P Kubelick; Da Huo; Jianguo Wen; Jinhwan Kim; Zhiheng Lyu; Simran Dhal; Alexandra Atalis; Shohini K Ghosh-Choudhary; Emily J Devereaux; James C Gumbart; Younan Xia; Stanislav Y Emelianov; Nick J Willett; Krishnendu Roy
Journal:  Nano Lett       Date:  2021-01-04       Impact factor: 11.189

Review 6.  Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors:  Babak Jalilian; Stig Hill Christiansen; Halldór Bjarki Einarsson; Mehdi Rasoli Pirozyan; Eskild Petersen; Thomas Vorup-Jensen
Journal:  Mol Cell Ther       Date:  2013-11-06

7.  Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines.

Authors:  Timothy Z Chang; Ishatou Diambou; Jong Rok Kim; Baozhong Wang; Julie A Champion
Journal:  Bioeng Transl Med       Date:  2017-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.